Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLNT
DateTimeSourceHeadlineSymbolCompany
07/01/20199:13AMPR Newswire (US)X-Biotix Therapeutics Joins Antimicrobials Working GroupNASDAQ:MLNTMelinta Therapeutics Inc
06/26/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/20/201911:13AMPR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019NASDAQ:MLNTMelinta Therapeutics Inc
06/19/20197:30AMGlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the ...NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/12/20191:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
06/11/20196:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
06/07/20194:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
06/07/20199:27AMPR Newswire (US)Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...NASDAQ:MLNTMelinta Therapeutics Inc
05/16/20195:31PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNTMelinta Therapeutics Inc
05/09/20194:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
05/09/20194:00PMGlobeNewswire Inc.Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
05/07/20197:30AMGlobeNewswire Inc.Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingNASDAQ:MLNTMelinta Therapeutics Inc
05/02/20194:30PMGlobeNewswire Inc.Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019NASDAQ:MLNTMelinta Therapeutics Inc
04/30/20196:18AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MLNTMelinta Therapeutics Inc
04/12/201910:08AMPR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a...NASDAQ:MLNTMelinta Therapeutics Inc
04/08/20197:30AMGlobeNewswire Inc.Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious D...NASDAQ:MLNTMelinta Therapeutics Inc
03/14/20197:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:MLNTMelinta Therapeutics Inc
03/13/20194:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
03/13/20194:00PMGlobeNewswire Inc.Melinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:MLNTMelinta Therapeutics Inc
03/05/20198:00AMGlobeNewswire Inc.Melinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019NASDAQ:MLNTMelinta Therapeutics Inc
02/26/20195:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
02/26/20195:17PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
02/25/20198:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
02/25/20198:15AMGlobeNewswire Inc.Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan FundingNASDAQ:MLNTMelinta Therapeutics Inc
02/21/20195:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT